BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Verastem, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-02-14 4:26 pm Purchase |
2024-12-31 | 13G | Verastem, Inc. VSTM |
BIOTECHNOLOGY VALUE FUND L P | 4,706,551 9.990% |
427,030![]() (+9.98%) |
Filing |
2024-11-14 4:38 pm Purchase |
2024-09-30 | 13G | Verastem, Inc. VSTM |
BIOTECHNOLOGY VALUE FUND L P | 4,279,521 9.990% |
1,662,119![]() (+63.50%) |
Filing |
2024-02-14 09:20 am Purchase |
2023-12-31 | 13G | Verastem, Inc. VSTM |
BIOTECHNOLOGY VALUE FUND L P | 2,617,402 9.990% |
2,617,402![]() (New Position) |
Filing |